BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2024 8:03:14 AM | Browse: 87 | Download: 184
 |
Received |
|
2024-01-08 09:14 |
 |
Peer-Review Started |
|
2024-01-08 09:14 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-04-30 06:42 |
 |
Revised |
|
2024-05-13 13:16 |
 |
Second Decision |
|
2024-06-21 02:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-06-21 06:52 |
 |
Articles in Press |
|
2024-06-21 06:52 |
 |
Publication Fee Transferred |
|
2024-07-06 04:51 |
 |
Edit the Manuscript by Language Editor |
|
2024-07-22 13:48 |
 |
Typeset the Manuscript |
|
2024-07-29 09:15 |
 |
Publish the Manuscript Online |
|
2024-08-16 08:03 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Biochemistry & Molecular Biology |
Manuscript Type |
Review |
Article Title |
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
An-Jie Guo, Qing-Yuan Deng, Pan Dong, Lian Zhou and Lei Shi |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Fundamental Research Funds for the Central Universities |
2019CDYGYB024 |
National Natural Science Foundation of China |
31300726 |
Chongqing Primary and Middle School Innovation Talent Training Project |
CY220113 |
|
Corresponding Author |
Lian Zhou, Head and Neck Cancer Center, Chongqing University Cancer Hospital, No. 181 Hanyu Road, Shapingba District, Chongqing 400000, China. zhoulianeve@163.com |
Key Words |
Immunotherapy; Immune checkpoint inhibitors; Immune-related adverse events; Biomarkers; Cancers |
Core Tip |
The development of effective biomarkers for precise immune-related adverse events (irAEs) prediction and diagnosis is urgently needed. Therefore, a comprehensive review of current studies on irAEs biomarkers is essential. This review encompasses major irAEs and provides an overview of existing biomarkers for prediction, diagnosis, and prognosis. Additionally, it explores diverse approaches for identifying novel, reliable biomarkers, including machine learning, single-cell RNA sequencing, multi-omics analysis, and gut microbiota assessment. Lastly, the review delves into the mechanisms underlying irAEs to enhance comprehension and guide the prediction, diagnosis, and management of these events. |
Publish Date |
2024-08-16 08:03 |
Citation |
<p>Guo AJ, Deng QY, Dong P, Zhou L, Shi L. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors. <i>World J Clin Oncol</i> 2024; 15(8): 1002-1020</p> |
URL |
https://www.wjgnet.com/2218-4333/full/v15/i8/1002.htm |
DOI |
https://dx.doi.org/10.5306/wjco.v15.i8.1002 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345